𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma

✍ Scribed by Keiko Furuta; Sachiko Misao; Kiyoshi Takahashi; Tsuneaki Tagaya; Yoshitaka Fukuzawa; Tetsuya Ishikawa; Kentaro Yoshioka; Shinichi Kakumu

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
146 KB
Volume
81
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive cancer cells. We examined if there is any TGF-beta1RII mutation in a coding microsatellite in hepatocellular carcinoma (HCC). Genomic DNAs were extracted from formalin-fixed, paraffin-embedded liver tissues obtained at surgery or autopsy in 3 normal individuals and 96 patients with hepatitis C virus-induced chronic liver disease; 3 with chronic hepatitis, 20 with liver cirrhosis and 73 with HCC. The DNA was PCR-amplified at 2 segments of TGF-beta1RII: poly A region which includes the (A)10 microsatellite sequence, and poly GT region. PCR products were directly sequenced. DNA from normal and patients with chronic liver disease contained the 10 wild-type adenines but 3 cases with liver cirrhosis in whom there were only 9 adenines within poly A tract. This microdeletion of one A resulted in a frameshift and truncated a predicted length of amino acids. In HCC lesions, the same deletion was noted in 4 cases (25%) of well-differentiated type, 10 (40%) of moderately differentiated type, 18 (53%) of poorly differentiated type. None of the lesions had mutations within the GT region. Our findings indicate that one adenine deletion of poly A microsatellite tract within TGF-beta1RII is frequently detected in patients with HCC, and the mutation may cause the abrogation of the function of TGF-beta1RII gene.

📜 SIMILAR VOLUMES

Structural alterations of transforming g
Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma
✍ Taiping Chen; E.G.E de Vries; H. Hollema; H.A. Yegen; V.F. Vellucci; H.D. Strick 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB

The development and progression of invasive uterine cervical carcinomas appear to be associated with the progressive loss of sensitivity to transforming growth factor-␤ (TGF␤)mediated cell cycle arrest. In order to identify possible molecular mechanisms responsible for TGF␤ resistance, we screened t

Enhanced tumorigenesis and reduced trans
Enhanced tumorigenesis and reduced transforming growth factor-β type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-β1
✍ Yang Kang; Jennifer M. Mariano; Jerry Angdisen; Terry W. Moody; Bhalchandra A. D 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

To elucidate the role of transforming growth factor-beta1 (TGF-beta1) and the TGF-beta type II receptor (TGF-beta RII) as tumor-suppressor genes in lung carcinogenesis, we mated C57BL/6 mice heterozygous (HT) for deletion of the TGF-beta1 gene with A/J mice to produce AJBL6 TGF-beta1 HT progeny and

Lack of transforming growth factor-β typ
Lack of transforming growth factor-β type II receptor expression in human retinoblastoma cells
✍ Kuniko Horie; Hidetoshi Yamashita; Akira Mogi; Seiichi Takenoshita; Kohei Miyazo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Retinoblastoma cells are resistant to transforming growth factor-b (TGF-b) activity due to the absence of TGF-b binding. To further elucidate the mechanism of TGF-b resistance, we studied the expression of the TGF-b receptors and SMADs by using the Y79 and WERI-Rb-1 retinoblastoma cell lines. Bindin

Dysregulated expression of transforming
Dysregulated expression of transforming growth factor β and its type-I and type-II receptors in basal-cell carcinoma
✍ Masutaka Furue; Mitsuyasu Kato; Koichiro Nakamura; Kiyoko Nashiro; Kanako Kikuch 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 256 KB 👁 1 views

In mammals, transforming growth factor-beta (TGF-beta) is found in 3 highly homologous isoforms that exert their effects via heteromeric complexes of type-I and type-II receptors (TbetaR-I and TbetaR-II). TGF-beta regulates the growth and metabolism of various cell types, including keratinocytes. We

Mutation of the transforming growth fact
Mutation of the transforming growth factor-β type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations
✍ Iacopetta, Barry J.; Welch, John; Soong, Richie; House, Anthony K.; Zhou, Xiao-P 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

The presence of inactivating mutations in the transforming growth factor-beta (TGF-beta) type II receptor (RII) gene in the colon cancer suggests that it may behave like a tumour suppressor gene. RII is mutated in the majority of colon tumours exhibiting widespread microsatellite instability, a char